After treatment with white button mushroom extract in mice and patients with prostate cancer, scientists discovered a decline ...

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

No man wants to hear that he has prostate cancer, but if he is diagnosed he will need to learn about the disease and how it ...

14, 2024 — Researchers have developed a three-dimensional mathematical model of prostate cancer. The model depicts various processes, including tumour growth, genetic evolution and tumour cell ...

Circulating tumor cell (CTC) count can help inform treatment decisions for patients with cancer, including which patients are ...

We’re finding that plant-derived substances may one day be used to support traditional cancer treatment and prevention ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study. The results could potentially lead to new therapies ...

A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine and University Hospital Cologne has ...

Prostate cancer is one of the most common cancers in men, and while many cases grow slowly and remain manageable, others can be aggressive and life-threatening. Over the years, treatments like surgery ...

Rupert Crowfoot, 57, was diagnosed with prostate cancer last year after a conversation with a friend encouraged him to get a ...